Results 1 to 10 of about 369,977 (276)

Immunotherapy for virus-related hepatocellular carcinoma: recent progress and future directions. [PDF]

open access: yesAnn Med
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, with hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remaining the predominant etiological factors. Chronic viral infection not only drives
Song R, Li M, Tang S, Zhang G.
europepmc   +2 more sources

Murine mammary tumor virus: characterization of infection of nonmurine cells [PDF]

open access: bronzeJournal of Virology, 1976
Murine mammary tumor virus (MuMTV) was used to productively infect feline and mink cells. MuMTV "proviral" DNA could be detected in the infected cells by molecular hybridization using radioactive MuMTV complementary DNA as a probe. Kinetic analysis of MuMTV proviral DNA synthesis after infection showed that maximum MuMTV DNA synthesis was achieved by 8
Akhil B. Vaidya   +4 more
openalex   +3 more sources

Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum,, [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2021
Infection with human papilloma virus (HPV) is related to a great number of cutaneous and mucosal manifestations. The spectrum of HPV ranges from inapparent infections, through various clinical benign presentations including cutaneous and mucosal disease,
Geraldo Magela Magalhães   +5 more
doaj   +1 more source

Autophagy Modulation by Viral Infections Influences Tumor Development

open access: yesFrontiers in Oncology, 2021
Autophagy is a self-degradative process important for balancing cellular homeostasis at critical times in development and/or in response to nutrient stress.
Lucas Leonardi   +9 more
doaj   +1 more source

Mouse Mammary Tumor Virus Infects Human Cells [PDF]

open access: yesCancer Research, 2005
Abstract Mouse mammary tumor virus (MMTV) has long been speculated to be involved in human breast cancer and more recently in human primary biliary cirrhosis. Despite complete proviral sequences markedly homologous to MMTV being identified in human breast cancer tissue, no convincing evidence has been presented to date that MMTV can ...
Stanislav, Indik   +3 more
openaire   +2 more sources

Giant anogenital tumor of Buschke–Löwenstein in a patient living with human immunodeficiency virus/acquired immunodeficiency syndrome: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Buschke–Löwenstein tumor is a giant condyloma acuminata infection that is characterized by degeneration, invasion, and recurrence. It is associated with human papilloma virus infection.
Mathurin Kowo   +5 more
doaj   +1 more source

Infective Substructures of Sendai Virus from Infected Ehrlich Ascites Tumor Cells [PDF]

open access: yesJournal of Virology, 1968
Increase of infectivity for embryonated eggs was observed in Ehrlich ascites tumor cells after intraperitoneal inoculation of Sendai virus into tumor-bearing mice. Virus-induced actinomycin-resistant ribonucleic acid consisting of 14 S , 18 S , 22 S , 35 S
A G, Bukrinskaya   +3 more
openaire   +2 more sources

The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy

open access: yesCells, 2022
Neutrophils are innate leukocytes with diverse effector functions that allow them to respond to pathogens rapidly. Accumulating evidence has highlighted these cells’ complex roles in the host’s response to viral infections and tumor progression ...
Jessica A. Minott   +5 more
doaj   +1 more source

Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H

open access: yesViruses, 2021
The coxsackievirus B3 strain PD-0 has been proposed as a new oncolytic virus for the treatment of colorectal carcinoma. Here, we generated a cDNA clone of PD-0 and analyzed the virus PD-H, newly generated from this cDNA, in xenografted and syngenic ...
Ahmet Hazini   +9 more
doaj   +1 more source

Virus infections in tumors pave the way for tumor-directed DC-vaccines [PDF]

open access: yesOncoImmunology, 2012
Effective treatment of solid cancers by tumor-directed DC-vaccines still remains a challenge in clinical oncology. For therapeutic success, knock-down of tumor-specific tolerance appears mandatory before a potent tumor-specific cytotoxic T-cell response can be triggered by DC-vaccinations.
Woller, Norman   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy